BioPharma

Why Choose Precipio?

We use proprietary and groundbreaking ICE COLD-PCR technology to enrich samples upstream for better accuracy and sensitivity for mutation detection. This technology coupled with our scientific, clinical and project management expertise makes us the ideal choice for your next Biomarker Identification Program.

Contact us about your program goals

The Science to Create Non-Invasive “Liquid Biopsies”

The ability to detect mutations from cell free DNA (cfDNA) in “liquid biopsies” enables more efficient and more effective clinical diagnosis and patient monitoring. Sampling is non-invasive, requiring only a blood draw, allowing simpler and more frequent sample collection. Precipio will help you design a “liquid biopsy” to detect the mutations in DNA isolated

from bodily fluids that are most appropriate for your product using our personalized biomarker development program.

Who Can Benefit from Our Services and Technology?

Pharma

Precipio will help you detect known and unknown genetic mutations in DNA isolated from blood, serum and other bodily fluids to advance your biomarker development program

Biotech

If you need to enrich any type of sample for mutant DNA, then take advantage of our proprietary ICE COLD-PCR technology

Clinical Diagnostics

Detecting small amounts of mutant DNA in a liquid or tissue sample can be impossible unless you let our ICE COLD-PCR technology enable you to detect known and unknown mutations with unheard of sensitivity

Oncologists

Precipio has made the possibility of true “Liquid Biopsies” a reality for the oncology community with our groundbreaking ICE COLD-PCR

State-of-the-art Compliance & Internal Processes

Pharma

Precipio will help you detect known and unknown genetic mutations in DNA isolated from blood, serum and other bodily fluids to advance your biomarker development program

Biotech

If you need to enrich any type of sample for mutant DNA, then take advantage of our proprietary ICE COLD-PCR technology

Clinical Diagnostics

Detecting small amounts of mutant DNA in a liquid or tissue sample can be impossible unless you let our ICE COLD-PCR technology enable you to detect known and unknown mutations with unheard of sensitivity

Interested in learning more? Call us at 203-787-7888
or email BD@precipiodx.com

We look forward to discussing how we can help you accelerate your biomarker discovery program